Siemens Healthineers and Carna Health Partner to Advance Kidney Care Innovation

Chronic kidney disease (CKD) is a growing global health challenge, particularly for high-risk and underserved populations. Early detection and management are essential but often hindered by limited access to diagnostic technologies and specialist care. Addressing these gaps requires scalable solutions that integrate early screening, timely referrals, and proactive management to reduce complications and healthcare costs.

Siemens Healthineers (Forchheim, Germany) has entered into a strategic agreement with Carna Health (Boston, MA, USA) to accelerate the adoption of Carna’s artificial intelligence (AI)-enabled CKD platform and bring industry-leading point-of-care testing systems to emerging markets. The agreement aims to improve early detection and CKD management for high-risk and underserved populations by integrating Carna’s digital platforms with Siemens’ global diagnostics infrastructure.

It also aims to simplify CKD workflow processes, creating better pathways for referrals and providing timely nephrology care to improve patient outcomes while reducing healthcare costs for both patients and healthcare systems. Carna’s platform enables healthcare providers to identify and track CKD through AI-driven clinical decision support and community-based screening programs.

A population-based CKD screening program in Bermuda and Limbe, Cameroon, is currently enrolling 30,000 individuals across the Southwest and Littoral regions. The program combines Carna’s digital platform with point-of-care eGFR testing performed on the epoc Blood Analysis System from Siemens to bring scalable, tech-driven solutions and lifesaving care to communities that face challenges in accessing care.

Carna Health aims to enroll 25 million people in CKD screening programs worldwide by 2030, with plans to expand the platform to screen for other cardiometabolic diseases including diabetes. The focus is on accelerating U.S. deployment and expanding technological compatibility across diverse healthcare environments—from rural clinics to large health systems.

“We have a shared commitment to expanding digital and diagnostic testing innovation access in regions around the world where such technologies have historically been limited,” said Bethany Costello, head of Global Strategy for point of care diagnostics at Siemens Healthineers. “Combining forces will build more equitable kidney care pathways for patients globally.”

“This strategic agreement marks a turning point in the fight against CKD,” said Salvatore Viscomi, MD, Co-Founder and Chief Executive Officer of Carna Health. “By combining Carna’s AI-enabled platform with global diagnostics expertise from Siemens Healthineers, we’re delivering a unified approach to early identification, continuous monitoring, and proactive management of CKD. Together we can detect disease sooner, connect patients to care faster, and enable interventions that change health outcomes and save lives.”

Related Links:
Siemens Healthineers 
Carna Health